Product NDC: | 76478-711 |
Proprietary Name: | Sodium Diuril |
Non Proprietary Name: | chlorothiazide sodium |
Active Ingredient(s): | .5 mg/18mL & nbsp; chlorothiazide sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76478-711 |
Labeler Name: | Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011145 |
Marketing Category: | NDA |
Start Marketing Date: | 19581003 |
Package NDC: | 76478-711-40 |
Package Description: | 12 VIAL in 1 CARTON (76478-711-40) > 18 mL in 1 VIAL |
NDC Code | 76478-711-40 |
Proprietary Name | Sodium Diuril |
Package Description | 12 VIAL in 1 CARTON (76478-711-40) > 18 mL in 1 VIAL |
Product NDC | 76478-711 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | chlorothiazide sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19581003 |
Marketing Category Name | NDA |
Labeler Name | Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) |
Substance Name | CHLOROTHIAZIDE SODIUM |
Strength Number | .5 |
Strength Unit | mg/18mL |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |